Though 5-FU is not an exception to the severe side effects induced during the treatment (5), its peculiarity to target TS expression independent of BC receptor status and the cost-effectiveness compared to other chemotherapeutics (6, 7), make it an absolute choice for chemotherapy for BC. The gene discussed is TYMS; the disease is breast cancer.